WEBINAR ON DEMAND
Duration: 1 hour
With increasing pressure to get to market faster, many biopharma organizations have turned to telegenetics to support clinical trial enrollment, engagement, and speed time-to-market. As they work to find and engage more people to enroll in studies, they’re operating in a changing landscape as trials become more decentralized and scientifically advanced. With value-added services such as genetic testing and counseling built into study protocols, biopharma companies not only benefit from knowing who qualifies for trials—but they also deepen their knowledge of the patient population and the genetic landscape for their therapeutics.
Join Genome Medical as they walk through these trends, discussing the role of telegenetics and how to build it into your research programs. You’ll learn: